PITUITARY ADENOMAS: PREVALENCE, PATHOGENESIS AND CLASSIFICATION OF DISEASE
Keywords:
pituitary adenoma (PA), hormone disturbance, chiasmus syndromeAbstract
Pathology of the chiasmal cellaric region is one of the most difficult areas in brain neurosurgery. But today, thanks to the introduction of new technologies, the diagnosis and treatment of pituitary adenomas (PA) has reached a new level, but it has not always been so. The literature review presents data on its latest achievements, development trends in the diagnosis and treatment of pituitary adenomas, with an overview of its history of development in the world.
References
Asa S.L., Ezzat S. The pathogenesis of pituitary tumors // Annu. Rev. Pathol. -2009. - 4. -Р. 97–126.
Aflorei E.D., Korbonits M. Epidemiology and etio- pathogenesis of pituitary adenomas // Journal of Neuro-Oncology. - 2014. - 117(3). - Р. 379– 394.
Ezzat S., Asa S.L., Couldwell W.T. et al. The preva- lence of pituitary adenomas: a systematic review // Cancer. - 2004. - 101(3). - Р. 613–619.
Burrow G.N., Wortzman G., Rewcastle N.B. et al. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series
// N. Engl. J. Med. - 1981. - 304(3). - P. 156–158.
Chambers E.F., Turski P.A., Lamasters D., Newton TH. Regions of low density in the contrasten- hanced pituitary gland: normal and pathologic processes. // Radiology. - 1982. - 144 (1). - P. 109–113.
Chong B.W., Kucharczyk W., Singer W., George S. Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas // AJNR Am. J. Neuroradiol. - 1994. - 15 (4). -P. 675–679.
Hall W.A., Luciano M.G., Doppman J.L. et al. Pituitary magnetic resonance imaging in normal hu- man volunteers: occult adenomas in the general population // Ann. Intern. Med. - 1994. - 120 (10).
- P. 817–820.
Muhr C., Bergstrom K., Grimelius L., Larsson S.G. A parallel study of the roentgen anatomy of the sella turcica and the histopathology of the pituitary gland in 205 autopsy specimens // Neu- roradiology. – 1981. - 21(2). – P. 55–65.
Parent A.D., Bebin J., Smith R.R. Incidental pitu- itary adenomas // J. Neurosurg. - 1981. - 54(2). - P. - 228–231.
Siqueira M.G., Guembarovski A.L. Subclinical pituitary microadenomas // Surg. Neurol. - 1984.- 22(2). – P. 134–140.
Teramoto A., Hirakawa K., Sanno N., Osamura Y. Incidental pituitary lesions in 1,000 unselected autopsy specimens // Radiology. - 1944. - 193
(1). – P. 161–164.
Tomita T., Gates E. Pituitary adenomas and granular cell tumors. Incidence, cell type, and location of tumor in 100 pituitary glands at autopsy
// Am. J. Clin. Pathol. - 1999. - 111(6). - P. 817–825.
Kane L.A., Leinung M.C., Scheithauer B.W. et al. Pituitary adenomas in childhood and adolescence // J. Clin. Endocrinol. Metab. - 1994. - 79(4).
–P. 1135–1140.
Laws E.R., Lanzino G. Classification, Pathobiology, Molecular Markers, and Intraoperative Pa thology // Transsphenoidal Surgery. Elsevier Inc.- 2010. – P. 70-91.
Hernandez-Ramirez L.C., Korbonits M. Familiar pituitary adenomas // Pituitary Disorders: Diag- nosis and Management. 1st ed. Eds. E.R. Laws,
S. Ezzat S.L. Asa M.L. Rio. L. Michel, R. Knutzen. John Wiley & Sons. - 2013. – P. 87-110.
Levy A. Molecular and trophic mechanisms of pituitary tumourigenesis // Horm Res Paediatr. - 2011. - 76 (Suppl 1). – P. 2–6.
Fernandez A., Karavitaki N., Wass J.A.H. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Ox- fordshire, UK) // Clin Endocrinol. - 2010. - 72: 3. – P. 377-382.
Мамедова Е.О., Пржиялковская Е.Г., Пигарова Е.А. Аденомы гипофиза в рамках наследственных синдромов // Проблемы эндокринологии. - 2014. -4. – С. 51.
Rostad S. Pituitary adenoma pathogenesis: an update // Curr Opin Endocrinol Diabetes Obes. - 2012. - 19(4). – P. 322.
Dworakowska D., Grossman A.B. The molecular pathogenesis of corticotroph tumours // Eur J Clin Invest. - 2012. - 42 (6). – P.665–76.
Tateno T., Asa S.L., Zheng L. et al. The FG- FR4-G388R polymorphism promotes mitochon- drial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis // PLoS Genet. - 2011. - 7(15).
Roussel-Gervais A., Bilodeau S., Vallette S. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis // Mol Endocrinol. - 2010.
- 24. – P. 1835–1845.
Xekouki P., Azevedo M., Stratakis C.A. Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways // Expert Rev Endocrinol Metab. - 2010. - 5. - P. 697–709.
Quereda V., Malumbres M. Cell cycle control of pituitary development and disease // J Mol Endocrinol. - 2009. - 42. – P. 75–86.
Yu R., Melmed S. Pituitary tumor transforming gene: an update // Front Horm Res. - 2004. - 32. - P. 175–185.
Grossman A.B. The molecular biology of pituitary tumors: a personal perspective // Pituitary.- 2009. - 12. – P. 265–270.
Garcıa-Fernandez R.A., Garcıa-Palencia P., San- chez M.A. Combined loss of p21(waf1/cip1) and p27(kip1) enhances tumorigenesis in mice
// Lab Invest. –2011. - 91. – P. 1634–1642.
